Stock listing
ASX:OSX Osteopore Ltd. Share Price
Follow Osteopore Ltd. into a list and get an email when it puts out news.
Share price · ASX:OSX
$0.0030 AUD 0.0000 (0.0%)
Close on Nov 19, 2026
- Day range
- $0.0030 – $0.0030 AUDNov 19, 2026
- Market cap
- $2.08M AUDAt the close on Nov 19, 2026 · price × 693.6M shares outstanding
- 52-week range
- $0.0030 – $0.0290 AUDLowest and highest trades, Nov 20, 2025 – Nov 19, 2026
- Traded on an average day
- $2,240 AUDMedian day 55,242 shares · 21 days with no trades · last 3 months, Aug 19, 2026 – Nov 19, 2026

Daily closes
Last 3 months, Aug 19, 2026 – Nov 19, 2026 · ASX:OSX · AUD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $0.0030 | 0.0000 | 0.0% | $0.0030 | $0.0030 | $0.0030 | 0 | |
| $0.0030 | 0.0000 | 0.0% | $0.0030 | $0.0030 | $0.0030 | 0 | |
| $0.0030 | 0.0000 | 0.0% | $0.0030 | $0.0030 | $0.0030 | 4,786 | |
| $0.0030 | 0.0000 | 0.0% | $0.0030 | $0.0030 | $0.0030 | 0 | |
| $0.0030 | 0.0000 | 0.0% | $0.0030 | $0.0030 | $0.0030 | 9,334 | |
| $0.0030 | 0.0000 | 0.0% | $0.0030 | $0.0030 | $0.0030 | 0 | |
| $0.0030 | 0.0000 | 0.0% | $0.0030 | $0.0030 | $0.0030 | 103,000 | |
| $0.0030 | -0.0005 | -14.3% | $0.0030 | $0.0030 | $0.0030 | 534 | |
| $0.0035 | 0.0000 | 0.0% | $0.0035 | $0.0035 | $0.0035 | 0 | |
| $0.0035 | 0.0000 | 0.0% | $0.0035 | $0.0035 | $0.0035 | 0 | |
| $0.0035 | +0.0005 | +16.7% | $0.0035 | $0.0035 | $0.0035 | 60,000 | |
| $0.0030 | -0.0010 | -25.0% | $0.0030 | $0.0030 | $0.0030 | 55,242 | |
| $0.0040 | 0.0000 | 0.0% | $0.0040 | $0.0040 | $0.0040 | 0 | |
| $0.0040 | 0.0000 | 0.0% | $0.0040 | $0.0040 | $0.0040 | 4,238,000 | |
| $0.0040 | 0.0000 | 0.0% | $0.0030 | $0.0040 | $0.0030 | 222,587 | |
| $0.0040 | 0.0000 | 0.0% | $0.0040 | $0.0040 | $0.0040 | 0 | |
| $0.0040 | 0.0000 | 0.0% | $0.0040 | $0.0040 | $0.0040 | 0 | |
| $0.0040 | 0.0000 | 0.0% | $0.0040 | $0.0040 | $0.0040 | 3,500 | |
| $0.0040 | 0.0000 | 0.0% | $0.0040 | $0.0040 | $0.0040 | 0 | |
| $0.0040 | 0.0000 | 0.0% | $0.0040 | $0.0040 | $0.0040 | 0 | |
| $0.0040 | 0.0000 | 0.0% | $0.0040 | $0.0040 | $0.0040 | 188,650 | |
| $0.0040 | +0.0010 | +33.3% | $0.0040 | $0.0040 | $0.0040 | 91,500 | |
| $0.0030 | 0.0000 | 0.0% | $0.0030 | $0.0030 | $0.0030 | 0 | |
| $0.0030 | 0.0000 | 0.0% | $0.0030 | $0.0030 | $0.0030 | 130,000 | |
| $0.0030 | 0.0000 | 0.0% | $0.0040 | $0.0040 | $0.0030 | 323,379 | |
| $0.0030 | -0.0010 | -25.0% | $0.0030 | $0.0030 | $0.0030 | 107,307 | |
| $0.0040 | 0.0000 | 0.0% | $0.0040 | $0.0040 | $0.0040 | 88,845 | |
| $0.0040 | +0.0005 | +14.3% | $0.0030 | $0.0040 | $0.0030 | 1,210,063 | |
| $0.0035 | 0.0000 | 0.0% | $0.0035 | $0.0035 | $0.0035 | 120,667 | |
| $0.0035 | 0.0000 | 0.0% | $0.0035 | $0.0035 | $0.0035 | 9 | |
| $0.0035 | -0.0005 | -12.5% | $0.0035 | $0.0035 | $0.0035 | 596,667 | |
| $0.0040 | +0.0010 | +33.3% | $0.0030 | $0.0040 | $0.0030 | 837,792 | |
| $0.0030 | -0.0010 | -25.0% | $0.0040 | $0.0040 | $0.0030 | 501,334 | |
| $0.0040 | 0.0000 | 0.0% | $0.0040 | $0.0040 | $0.0040 | 0 | |
| $0.0040 | +0.0010 | +33.3% | $0.0040 | $0.0040 | $0.0040 | 837,531 | |
| $0.0030 | 0.0000 | 0.0% | $0.0030 | $0.0030 | $0.0030 | 0 | |
| $0.0030 | -0.0015 | -33.3% | $0.0040 | $0.0040 | $0.0030 | 1,675,892 | |
| $0.0045 | 0.0000 | 0.0% | $0.0045 | $0.0045 | $0.0045 | 0 | |
| $0.0045 | +0.0005 | +12.5% | $0.0040 | $0.0045 | $0.0040 | 690,000 | |
| $0.0040 | 0.0000 | 0.0% | $0.0040 | $0.0040 | $0.0040 | 125,000 | |
| $0.0040 | 0.0000 | 0.0% | $0.0035 | $0.0040 | $0.0035 | 4,522,302 | |
| $0.0040 | +0.0010 | +33.3% | $0.0040 | $0.0040 | $0.0040 | 2,235 | |
| $0.0030 | 0.0000 | 0.0% | $0.0030 | $0.0030 | $0.0030 | 137,644 | |
| $0.0030 | -0.0010 | -25.0% | $0.0030 | $0.0030 | $0.0030 | 427 | |
| $0.0040 | 0.0000 | 0.0% | $0.0040 | $0.0040 | $0.0040 | 0 | |
| $0.0040 | 0.0000 | 0.0% | $0.0040 | $0.0040 | $0.0040 | 800,000 | |
| $0.0040 | 0.0000 | 0.0% | $0.0040 | $0.0040 | $0.0040 | 130,000 | |
| $0.0040 | 0.0000 | 0.0% | $0.0040 | $0.0040 | $0.0040 | 1,175,000 | |
| $0.0040 | 0.0000 | 0.0% | $0.0040 | $0.0040 | $0.0030 | 6,285,054 | |
| $0.0040 | 0.0000 | 0.0% | $0.0040 | $0.0040 | $0.0040 | 800,000 | |
| $0.0040 | 0.0000 | 0.0% | $0.0040 | $0.0040 | $0.0040 | 0 | |
| $0.0040 | -0.0010 | -20.0% | $0.0040 | $0.0040 | $0.0040 | 2,955,948 | |
| $0.0050 | 0.0000 | 0.0% | $0.0050 | $0.0050 | $0.0050 | 0 | |
| $0.0050 | +0.0010 | +25.0% | $0.0050 | $0.0050 | $0.0050 | 50,000 | |
| $0.0040 | -0.0010 | -20.0% | $0.0040 | $0.0040 | $0.0040 | 6,468,248 | |
| $0.0050 | 0.0000 | 0.0% | $0.0050 | $0.0050 | $0.0050 | 50,000 | |
| $0.0050 | 0.0000 | 0.0% | $0.0050 | $0.0050 | $0.0050 | 400 | |
| $0.0050 | +0.0005 | +11.1% | $0.0050 | $0.0050 | $0.0050 | 378,221 | |
| $0.0045 | 0.0000 | 0.0% | $0.0045 | $0.0045 | $0.0045 | 0 | |
| $0.0045 | 0.0000 | 0.0% | $0.0045 | $0.0045 | $0.0045 | 0 | |
| $0.0045 | +0.0005 | +12.5% | $0.0040 | $0.0050 | $0.0040 | 126,898 | |
| $0.0040 | 0.0000 | 0.0% | $0.0040 | $0.0040 | $0.0040 | 0 | |
| $0.0040 | -0.0005 | -11.1% | $0.0045 | $0.0045 | $0.0040 | 66,105 | |
| $0.0045 | 0.0000 | 0.0% | $0.0045 | $0.0045 | $0.0045 | 25,000 | |
| $0.0045 | 0.0000 | 0.0% | $0.0045 | $0.0045 | $0.0045 | 417,249 | |
| $0.0045 | -0.0005 | -10.0% | $0.0045 | $0.0045 | $0.0045 | 50,000 | |
| $0.0050 | 0.0000 | 0.0% | $0.0050 | $0.0050 | $0.0050 | 1,150,000 |
Splits
1 split · ASX:OSX · every price before a split is adjusted for it
| Day | Ratio | What |
|---|---|---|
| 1-for-15 | Consolidation |
- Ticker
- ASX:OSX
- Asset type
- Stock
- Sector
- Health care
- Industry
- Medical devices & supplies
- Exchange
- ASX
- Currency
- AUD
What changed lately
Latest news release · Nov 1, 2026
OSX focuses on Ortho line in Singapore via direct selling
Latest news
OSX focuses on Ortho line in Singapore via direct selling
Nov 1, 2026
Closed $0.0040 (0.0%) on Nov 2, 2026
Activities Report September 2026 and Appendix 4C
Oct 30, 2026
Closed $0.0040 (0.0%) on Nov 2, 2026
Resignation and appointment of Company Secretary
Oct 2, 2026
Closed $0.0040 (+33.3%) on Oct 2, 2026
OSX secures market access to Thailand orthopaedic market
Sep 8, 2026
Closed $0.0040 (-20.0%) on Sep 9, 2026
Half Yearly Report and Accounts
Aug 31, 2026
Closed $0.0050 (+11.1%) on Sep 1, 2026
OSX strikes orthopaedic deal for 5 Middle East countries
Aug 5, 2026
Closed $0.0050 (+11.1%) on Aug 6, 2026
Details of Auditor Appointment/Resignation
Aug 3, 2026
Closed $0.0045 (0.0%) on Aug 4, 2026
OSX completes first Hainan custom orthopaedic implant
Aug 2, 2026
Closed $0.0045 (0.0%) on Aug 3, 2026
Activities Report June 2026 and Appendix 4C
Jul 30, 2026
Closed $0.0045 (0.0%) on Jul 31, 2026
OSX secures Hainan FDA approval for orthopaedic devices
May 25, 2026
Closed $0.0070 (+16.7%) on May 26, 2026
Osteopore Ltd. on 6ix
- Sector
- Health care
- Industry
- Medical devices & supplies
- News releases
- 26 in the last 12 months · 118 in all · newest Nov 1, 2026 · oldest 2019
- Decks
- 11 decks · latest March 2025
Valuation
EV/sales 0.3× against a median of 0.5×: 4th lowest of 8 Medical devices & supplies companies shown. Statements: Year to Dec 31, 2025 · balance Jun 30, 2026 · price Nov 19, 2026
- Enterprise value
- $900,557 AUD
- P/E
- Loss
- EV/sales
- 0.3×
- EV/EBITDA
- Negative EBITDA
- Price/book
- Negative equity
- Gross margin
- 53.0%
- Operating margin
- −87.4%
- Net margin
- −121.8%
- Debt to equity
- Negative equity
- Beta
- No index for this market yet
Medical devices & supplies: the 10 companies nearest in size, of 448 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| Osteopore Ltd. · ASX:OSX | US$1.38M | US$596,079 | n/a | 0.3× | n/a | n/a | −121.8% | n/a | n/a |
| Fuse Medical, Inc. · OTC:FZMD | US$2.03M | US$4.31M | 14.8× | 0.5× | 7.8× | 0.3× | 1.5% | 0.4× | 0.54 |
| Nuwellis, Inc. · NASDAQ:NUWE | US$1.84M | −US$6.31M | n/a | −0.7× | n/a | 0.2× | −152.8% | 0.0× | 2.26 |
| Vivos Therapeutics, Inc. · NASDAQ:VVOS | US$1.83M | US$2.11M | n/a | 0.1× | n/a | 0.8× | −107.1% | 0.2× | 1.41 |
| Autonomix Medical, Inc. · NASDAQ:AMIX | US$1.82M | −US$5.87M | n/a | n/a | n/a | 0.3× | n/a | 0.0× | 1.79 |
| Adagio Medical Holdings, Inc · NASDAQ:ADGM | US$1.72M | US$636,010 | 2.1× | n/a | n/a | 0.1× | n/a | 0.1× | 0.69 |
| Escalon Medical Corp. · OTC:ESMC | US$1.71M | −US$1.96M | 0.4× | −0.1× | n/a | 0.3× | 32.8% | 0.0× | -0.06 |
| Therma Bright Inc. · TSXV:THRM | US$1.66M | US$1.64M | n/a | 17.3× | n/a | n/a | n/a | n/a | -0.15 |
| Nexalin Technology, Inc. · NASDAQ:NXL | US$1.45M | US$1.88M | n/a | 6.8× | n/a | 5.5× | n/a | 4.7× | 0.52 |
| Zero Candida Technologies Inc. · TSXV:ZCT | US$1.43M | −US$59,297 | n/a | n/a | n/a | 2.2× | n/a | 0.0× | -0.17 |
| SpectraCure AB · OMXSTO:SPEC | US$978,306 | US$1.10M | n/a | 32.1× | n/a | 0.1× | n/a | 0.1× | n/a |
| Median of the others | US$1.71M | US$869,802 | 2.1× | 0.5× | 7.8× | 0.3× | −52.8% | 0.1× | 0.54 |
Team and board
Officers
| Officer | Role |
|---|---|
| Lim Yujing | Chief Technology Officer |
| Harry Miller | Company Secretary |
| Ammar Hassanbhai | Senior Manager, Quality Assurance |
| James Lim Jae Hoon | Country Manager, Korea, Global Business Director, Aesthetic Rhinoplasty |
| Mark Leong | Executive Chairman |
| Voon Shu Ning | Group Financial Controller |
Board
| Director | Role |
|---|---|
| Mark Leong | Executive Chairman |
| Michael Keenan | Non-Executive Director |
| Teoh Swee Hin | Non-Executive Director |
Events
| Quarter | Results | Share move |
|---|---|---|
| Q2 2025 | Aug 29, 2025 | 0.0% |
| Quarter to Mar 31, 2025 | Apr 7, 2025 | −20.0% |
| Q4 2022 | Feb 28, 2023 · After close | 0.0% |
| Q2 2022 | Aug 31, 2022 | −5.0% |
| Q4 2021 | Mar 31, 2022 | 0.0% |
| Q2 2021 | Aug 31, 2021 | +5.9% |
| Q4 2020 | Feb 26, 2021 | −2.2% |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Investor Presentation (March 2025) | Investor deck | 29 slides | March 2025 |
| Investor Presentation (August 2023) | Investor deck | 39 slides | Aug 1, 2023 |
| Investor Presentation (February 2023) | Investor deck | 28 slides | Feb 20, 2023 |
| Investor Presentation (August 2022) | Investor deck | 22 slides | Aug 10, 2022 |
| Investor Presentation (November 2021) | Investor deck | 17 slides | Nov 22, 2021 |
| Investor Presentation (June 2021) | Investor deck | 17 slides | Jun 10, 2021 |
| Investor Presentation (March 2021) | Investor deck | 28 slides | Mar 22, 2021 |
| Investor Presentation (November 2020) | Investor deck | 13 slides | Nov 24, 2020 |
| Investor Presentation (August 2020) | Investor deck | 36 slides | Aug 21, 2020 |
| Investor Presentation (February 2020) | Investor deck | 31 slides | Feb 7, 2020 |
All 11 decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Investor Presentation (October 2019) | Investor deck | 30 slides | Oct 22, 2019 |
Financials
Annual, in AUD
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 3.06M | 2.81M | 2.22M | 1.69M | 1.11M | 1.50M | 414.1K | 934.9K | 610.6K | 204.8K |
| Cost of revenue | 1.44M | 445.5K | 581.5K | 419.1K | 301.4K | 549.3K | 123.5K | 216.5K | 143.2K | 82.8K |
| Gross profit | 1.62M | 2.37M | 1.64M | 1.27M | 811.6K | 955.3K | 290.6K | 718.4K | 467.4K | 122.0K |
| Research and development | 1.45M | 1.14M | 1.57M | 1.43M | ||||||
| Selling, general and administrative | 3.74M | 2.21M | 2.03M | 4.52M | 4.20M | 3.28M | 1.53M | 1.45M | 824.1K | 1.03M |
| Operating income | -2.67M | -2.82M | -4.93M | -4.22M | -3.89M | -2.64M | -2.37M | -901.9K | -528.9K | -1.06M |
| Depreciation and amortization | 748.7K | 531.1K | 464.4K | 218.2K | 225.5K | 165.9K | 72.6K | 77.1K | 72.9K | 48.3K |
| EBITDA | -1.92M | -2.29M | -4.46M | -4.00M | -3.67M | -2.48M | -2.29M | -824.9K | -456.0K | -1.01M |
| Interest expense | 280.0K | 426.0K | 15.0K | 20.4K | 16.3K | 17.6K | 15.6K | 0 | 0 | 0 |
| Income before tax | -3.72M | -3.33M | -4.83M | -4.20M | -3.62M | -1.95M | -2.38M | -870.2K | -447.0K | -972.8K |
| Income tax | 1.67K | 19.2K | 43.5K | 20.4K | 307.8K | 742.1K | 18.1K | 3 | -1 | |
| Net income | -3.72M | -3.35M | -4.87M | -4.22M | -3.62M | -1.95M | -2.38M | -870.2K | -447.0K | -972.8K |
| Earnings per share, basic | -0.02 | -0.04 | -0.08 | -0.51 | -0.46 | -0.27 | -1.24 | -0.02 | -0.01 | -0.03 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 627.0K | 638.5K | 1.16M | 2.16M | 4.93M | 9.03M | 3.29M | 4.99M | 33.8K | 28.9K |
| Short-term investments | 5.92K | 5.75K | 5.56K | 13.1K | 201.6K | 16.4K | 15.8K | 9.94K | 9.91K | |
| Receivables | 1.05M | 1.07M | 643.0K | 866.3K | 400.7K | 361.4K | 542.2K | 223.9K | 106.9K | 575.3K |
| Inventory | 362.9K | 379.5K | 279.0K | 279.2K | 201.6K | 151.4K | 23.5K | 28.1K | 23.7K | 45.1K |
| Current assets | 2.59M | 2.35M | 2.28M | 3.15M | 5.42M | 9.74M | 3.97M | 5.24M | 164.3K | 649.4K |
| Property, plant and equipment | 183.4K | 322.5K | 285.1K | 467.2K | 587.8K | 506.3K | 309.9K | 167.4K | 177.7K | 209.4K |
| Total assets | 2.77M | 3.13M | 3.34M | 3.62M | 6.01M | 10.2M | 4.28M | 5.40M | 349.6K | 858.8K |
| Accounts payable | 1.62M | 647.0K | 785.9K | 1.37M | 450.8K | 325.7K | 211.4K | 166.7K | 44.5K | 13.9K |
| Current liabilities | 3.05M | 2.72M | 2.91M | 1.48M | 564.5K | 1.25M | 1.29M | 1.17M | 2.18M | 2.22M |
| Long-term debt | 1.41M | |||||||||
| Total debt | 198.8K | 1.33M | 1.09M | 74.2K | 148.8K | 454.0K | 596.6K | 665.8K | 510.2K | 209.3K |
| Total liabilities | 4.50M | 2.83M | 2.91M | 1.51M | 633.4K | 1.25M | 1.32M | 1.17M | 2.18M | 2.22M |
| Shareholders' equity | -1.73M | 306.2K | 432.6K | 2.11M | 5.37M | 9.00M | 2.97M | 4.23M | -1.84M | -1.36M |
| Shares outstanding | 186.1M | 78.3M | 57.8M | 8.24M | 7.82M | 7.11M | 1.92M | 38.2M | 38.2M | 38.2M |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | -2.56M | -3.09M | -3.74M | -4.00M | -3.81M | -1.76M | -1.75M | -334.1K | 11.2K | -184.3K |
| Capital spending | -10.8K | -14.6K | -7.37K | -64.0K | -194.6K | -381.0K | -78.3K | -66.5K | -49.2K | -73.6K |
| Free cash flow | -2.57M | -3.10M | -3.74M | -4.06M | -4.00M | -2.14M | -1.83M | -400.6K | -38.0K | -257.9K |
| Cash from investing | -10.8K | -14.6K | -7.37K | -64.0K | -194.6K | -381.0K | 407.3K | 1.47M | -49.2K | -73.6K |
| Cash from financing | 2.67M | 2.63M | 3.58M | 896.3K | -485.9K | 7.84M | 4.64M | -602.1K | 35.6K | 263.2K |
| Dividends paid | -48.7K | |||||||||
| Share buybacks | 0 | -109.6K | -169.8K | -54.1K | 0 | -563.4K | -241.7K | |||
| Change in cash | -5.78K | -476.3K | -219.4K | -3.20M | -4.50M | 5.73M | 3.29M | 505.1K | 4.86K | 5.27K |
Filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| OSX focuses on Ortho line in Singapore via direct selling | Nov 1, 2026 | Operations update | ASX |
| Activities Report September 2026 and Appendix 4C | Oct 30, 2026 | Quarterly report | ASX |
| Resignation and appointment of Company Secretary | Oct 2, 2026 | Management or board change | ASX |
| OSX secures market access to Thailand orthopaedic market | Sep 8, 2026 | Operations update | ASX |
| Half Yearly Report and Accounts | Aug 31, 2026 | Interim report | ASX |
| OSX strikes orthopaedic deal for 5 Middle East countries | Aug 5, 2026 | Acquisition or disposal | ASX |
| Details of Auditor Appointment/Resignation | Aug 3, 2026 | Other filings | ASX |
| OSX completes first Hainan custom orthopaedic implant | Aug 2, 2026 | Operations update | ASX |
| Activities Report June 2026 and Appendix 4C | Jul 30, 2026 | Quarterly report | ASX |
| OSX secures Hainan FDA approval for orthopaedic devices | May 25, 2026 | Operations update | ASX |
All 115 filings
Cap table
Built by 6ix from Osteopore Ltd.’s releases
- Common shares
- 693,592,914
- Fully diluted
- 693,592,914
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 693,592,914 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 693,592,914 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Ammar Hassanbhai | Senior Manager, Quality Assurance · Since at least Nov 4, 2026 |
| Harry Miller | Company Secretary · Since at least Oct 2, 2026 |
| Jack Rosagro | Until Oct 2, 2026 · Past |
| James Lim Jae Hoon | Country Manager, Korea, Global Business Director, Aesthetic Rhinoplasty · Since at least Nov 4, 2026 |
| Lim Yujing | Chief Technology Officer · Since at least May 12, 2025 |
| Mark Leong | Executive Chairman · Since at least Nov 5, 2026 |
| Michael Keenan | Non-Executive Director · Since at least Nov 5, 2026 |
| Teoh Swee Hin | Non-Executive Director · Since at least Nov 5, 2026 |
| Voon Shu Ning | Group Financial Controller · Since at least Nov 4, 2026 |
Log in to ask 6ix AI your own questions about Osteopore Ltd.